Literature DB >> 31560862

A modified cholera toxin B subunit containing an ER retention motif enhances colon epithelial repair via an unfolded protein response.

Joshua M Royal1, Young Jun Oh1, Michael J Grey2,3, Wayne I Lencer2,3, Nemencio Ronquillo4, Susan Galandiuk5, Nobuyuki Matoba1.   

Abstract

Cholera toxin B subunit (CTB) exhibits broad-spectrum biologic activity upon mucosal administration. Here, we found that a recombinant CTB containing an endoplasmic reticulum (ER) retention motif (CTB-KDEL) induces colon epithelial wound healing in colitis via the activation of an unfolded protein response (UPR) in colon epithelial cells. In a Caco2 cell wound healing model, CTB-KDEL, but not CTB or CTB-KDE, facilitated cell migration via interaction with the KDEL receptor, localization in the ER, UPR activation, and subsequent TGF-β signaling. Inhibition of the inositol-requiring enzyme 1/X-box binding protein 1 arm of UPR abolished the cell migration effect of CTB-KDEL, indicating that the pathway is indispensable for the activity. CTB-KDEL's capacity to induce UPR and epithelial restitution or wound healing was corroborated in a dextran sodium sulfate-induced acute colitis mouse model. Furthermore, CTB-KDEL induced a UPR, up-regulated wound healing pathways, and maintained viable crypts in colon explants from patients with inflammatory bowel disease (IBD). In summary, CTB-KDEL exhibits unique wound healing effects in the colon that are mediated by its localization to the ER and subsequent activation of UPR in epithelial cells. The results provide implications for a novel therapeutic approach for mucosal healing, a significant unmet need in IBD treatment.-Royal, J. M., Oh, Y. J., Grey, M. J., Lencer, W. I., Ronquillo, N., Galandiuk, S., Matoba, N. A modified cholera toxin B subunit containing an ER retention motif enhances colon epithelial repair via an unfolded protein response.

Entities:  

Keywords:  IBD; TGF-β; epithelial restitution; wound healing

Mesh:

Substances:

Year:  2019        PMID: 31560862      PMCID: PMC9272749          DOI: 10.1096/fj.201901255R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.834


  71 in total

Review 1.  Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease.

Authors:  Ambrogio Orlando; Francesco William Guglielmi; Mario Cottone; Emanuele Orlando; Claudia Romano; Emanuele Sinagra
Journal:  Dig Liver Dis       Date:  2013-08-28       Impact factor: 4.088

2.  Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway.

Authors:  Hee Jun Cho; Kyoung Eun Baek; Shizuya Saika; Moon-Jin Jeong; Jiyun Yoo
Journal:  Biochem Biophys Res Commun       Date:  2006-12-14       Impact factor: 3.575

Review 3.  Wound healing of intestinal epithelial cells.

Authors:  Masahiro Iizuka; Shiho Konno
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

4.  In Situ Proximity Ligation Assay (PLA).

Authors:  Sonchita Bagchi; Robert Fredriksson; Åsa Wallén-Mackenzie
Journal:  Methods Mol Biol       Date:  2015

5.  Increased sensitivity to dextran sodium sulfate colitis in IRE1beta-deficient mice.

Authors:  A Bertolotti; X Wang; I Novoa; R Jungreis; K Schlessinger; J H Cho; A B West; D Ron
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

6.  Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis.

Authors:  M Boirivant; I J Fuss; L Ferroni; M De Pascale; W Strober
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

7.  E-cadherin is critical for collective sheet migration and is regulated by the chemokine CXCL12 protein during restitution.

Authors:  Soonyean Hwang; Noah P Zimmerman; Kimberle A Agle; Jerrold R Turner; Suresh N Kumar; Michael B Dwinell
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

Review 8.  Epithelial restitution and wound healing in inflammatory bowel disease.

Authors:  Andreas Sturm; Axel U Dignass
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 9.  Cholera toxin: an intracellular journey into the cytosol by way of the endoplasmic reticulum.

Authors:  Naomi L B Wernick; Daniel J-F Chinnapen; Jin Ah Cho; Wayne I Lencer
Journal:  Toxins (Basel)       Date:  2010-03-05       Impact factor: 4.546

10.  E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma.

Authors:  K Araki; T Shimura; H Suzuki; S Tsutsumi; W Wada; T Yajima; T Kobayahi; N Kubo; H Kuwano
Journal:  Br J Cancer       Date:  2011-11-08       Impact factor: 7.640

View more
  6 in total

Review 1.  KDEL Receptors: Pathophysiological Functions, Therapeutic Options, and Biotechnological Opportunities.

Authors:  Ilaria Cela; Beatrice Dufrusine; Claudia Rossi; Alberto Luini; Vincenzo De Laurenzi; Luca Federici; Michele Sallese
Journal:  Biomedicines       Date:  2022-05-25

2.  Isolation and detection of a KDEL-tagged recombinant cholera toxin B subunit from Nicotiana benthamiana.

Authors:  David A Morris; Micaela A Reeves; Joshua M Royal; Krystal T Hamorsky; Nobuyuki Matoba
Journal:  Process Biochem       Date:  2020-11-04       Impact factor: 3.757

3.  A modified cholera toxin B subunit containing an ER retention motif enhances colon epithelial repair via an unfolded protein response.

Authors:  Joshua M Royal; Young Jun Oh; Michael J Grey; Wayne I Lencer; Nemencio Ronquillo; Susan Galandiuk; Nobuyuki Matoba
Journal:  FASEB J       Date:  2019-09-27       Impact factor: 5.834

Review 4.  Harnessing the Membrane Translocation Properties of AB Toxins for Therapeutic Applications.

Authors:  Numa Piot; F Gisou van der Goot; Oksana A Sergeeva
Journal:  Toxins (Basel)       Date:  2021-01-06       Impact factor: 4.546

5.  Spray-Dried Formulation of Epicertin, a Recombinant Cholera Toxin B Subunit Variant That Induces Mucosal Healing.

Authors:  Micaela A Reeves; Joshua M Royal; David A Morris; Jessica M Jurkiewicz; Nobuyuki Matoba; Krystal T Hamorsky
Journal:  Pharmaceutics       Date:  2021-04-18       Impact factor: 6.321

6.  Repeated Oral Administration of a KDEL-tagged Recombinant Cholera Toxin B Subunit Effectively Mitigates DSS Colitis Despite a Robust Immunogenic Response.

Authors:  Joshua M Royal; Micaela A Reeves; Nobuyuki Matoba
Journal:  Toxins (Basel)       Date:  2019-11-20       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.